Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03184558
Title BGB324 in Combination With Pembrolizumab in Patients With TNBC
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors BerGenBio ASA
Age Groups: senior | adult
Covered Countries USA | GBR | ESP

No variant requirements are available.